Todd E.H. Hecht

ORCID: 0000-0001-8266-1432
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Venous Thromboembolism Diagnosis and Management
  • Vascular Procedures and Complications
  • Atrial Fibrillation Management and Outcomes
  • Acute Myocardial Infarction Research
  • Central Venous Catheters and Hemodialysis
  • Pharmaceutical Economics and Policy
  • Microscopic Colitis
  • Diversity and Career in Medicine
  • Pharmacovigilance and Adverse Drug Reactions
  • COVID-19 and healthcare impacts
  • COVID-19 Clinical Research Studies
  • Pharmaceutical Practices and Patient Outcomes
  • Inflammatory Bowel Disease
  • Health Systems, Economic Evaluations, Quality of Life
  • Pharmaceutical industry and healthcare
  • Cardiac, Anesthesia and Surgical Outcomes
  • Pharmaceutical studies and practices
  • Autoimmune and Inflammatory Disorders
  • Radiology practices and education
  • Quality and Safety in Healthcare
  • Bariatric Surgery and Outcomes
  • Clinical practice guidelines implementation
  • Acute Ischemic Stroke Management
  • Blood Pressure and Hypertension Studies
  • Gastrointestinal disorders and treatments

University of Pennsylvania
2003-2023

Hospital of the University of Pennsylvania
2012-2015

University of Pennsylvania Health System
2008

Abstract Background Previous research has suggested that daily lottery incentives could improve medication adherence. Such include implicit reminders. However, the comparative effectiveness of reminders alone versus not been tested. Methods A total 270 patients on warfarin were enrolled in a four‐arm, multi‐center, randomized controlled trial comparing lottery‐based incentive, reminder, and combination two against control group (usual care). Results Participants reminder had lowest...

10.1002/pds.4094 article EN Pharmacoepidemiology and Drug Safety 2016-09-04

Venous thromboembolism (VTE) causes morbidity and mortality in hospitalized patients, regulators payors are encouraging the use of systems to prevent them. Here, we examine effect a computerized clinical decision support (CDS) intervention implemented across multi-hospital academic health system on VTE prophylaxis events. The study included 223,062 inpatients admitted between April 2007 May 2010, used administrative data. was integrated into commercial electronic record (EHR) an admission...

10.1186/1472-6947-12-92 article EN cc-by BMC Medical Informatics and Decision Making 2012-08-31

Pharmacological thromboprophylaxis is necessary among many hospitalised patients to prevent venous thromboembolism (VTE). However, a significant number of clinician-ordered doses are not administered with refused by patients. We aimed assess the impact and sustainability multifaceted intervention improve medication adherence pharmacological thromboprophylaxis. The included standardised nursing response patient refusal, daily assessment VTE prophylaxis usage regular feedback on refusal...

10.1136/bmjqs-2015-003992 article EN BMJ Quality & Safety 2015-06-02

Drug‐drug interactions (DDIs) with oral anticoagulants may lead to under‐anticoagulation and increased risk of thromboembolism. Although warfarin is susceptible numerous DDIs, few studies have examined DDIs resulting in thromboembolism or those involving direct‐acting (DOACs). We aimed identify medications that increase the rate hospitalization for thromboembolic events when taken concomitantly anticoagulants. conducted a high‐throughput pharmacoepidemiologic screening study using Optum...

10.1002/cpt.1845 article EN Clinical Pharmacology & Therapeutics 2020-04-10

Venous thromboembolism (VTE) is a potentially preventable complication following surgery. There variation with regard to the most effective mode of prophylaxis. We sought determine if an aggressive approach VTE prophylaxis would reduce rates on inpatient vascular surgical service.Vascular inpatients from single institution July 2010 March 2013 were included in analysis. A protocol for was implemented service November 2011. This subcutaneous (SQ) heparin initiation within 24 h admission...

10.1177/1708538115594094 article EN Vascular 2015-06-29

Abstract Background Usage of medication brand names in electronic health records may introduce conflicts interest, perpetuate false perceptions superiority, alter prescribing practices, and cause confusion leading to errors. Objective We sought identify the frequency name usage clinical documentation, as well factors associated with increased usage. Designs, Settings, Participants conducted a retrospective analysis all documentation written at our healthcare system (a multifacility academic...

10.1002/jhm.13170 article EN Journal of Hospital Medicine 2023-07-24

INTRODUCTION: Risk prediction scores have been devised to identify patients at increased risk for Venous Thromboembolism (VTE) in different patient populations and settings. Guideline recommendations VTE assessment vary greatly. We performed a systematic review synthesize evidence on clinical hospitalized medical surgical patients. METHODS: systematically searched Medline, EMBASE, Cochrane, National Institute of Health Care Excellence (NICE), Guidelines Clearinghouse (NGC), International...

10.1017/s0266462317002094 article EN International Journal of Technology Assessment in Health Care 2017-01-01

Abstract Background: Usage of medication brand names in electronic health records may introduce conflicts interest, perpetuate false perceptions superiority, alter prescribing practices, and cause confusion leading to errors. We sought identify the frequency name usage clinical documentation, as well factors associated with increased usage. Methods: conducted a descriptive analysis generic for 518 medications all notes written at our healthcare system between 2015 2020. used string-matching...

10.21203/rs.3.rs-1705486/v1 preprint EN cc-by Research Square (Research Square) 2022-07-06

Background and Objectives: Warfarin a skeletal muscle relaxant are co-treatments in nearly quarter-million annual United States (US) office visits. Despite international calls to minimize patient harm arising from anticoagulant drug interactions, scant data exist on clinical outcomes real-world populations. We examined effects of concomitant use warfarin individual relaxants rates hospitalization for thromboembolism among economically disadvantaged persons. Materials Methods: Using 1999−2012...

10.3390/medicina58091171 article EN cc-by Medicina 2022-08-29
Coming Soon ...